Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?

[1]  P. Sevelda,et al.  [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125]. , 1987, Wiener klinische Wochenschrift.

[2]  R. Bast,et al.  CA 125 serum levels correlated with second-look operations among ovarian cancer patients. , 1986, Obstetrics and gynecology.

[3]  R. Bast,et al.  Preoperative Evaluation of Serum CA 125 Levels in Patients With Primary Epithelial Ovarian Cancer , 1986, Obstetrics and gynecology.

[4]  R. Bast,et al.  Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer. , 1985, American journal of obstetrics and gynecology.

[5]  R. Bast,et al.  CA125 Antigen Levels in Obstetric and Gynecologic Patients , 1984, Obstetrics and gynecology.

[6]  R. Bast,et al.  Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. , 1984, Cancer research.

[7]  R. Bast,et al.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983, The New England journal of medicine.

[8]  R. Bast,et al.  Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.

[9]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[10]  V. Lorusso,et al.  CA 125 in the monitoring of response to chemotherapy of ovarian carcinoma , 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.